{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6(12)"],"submitter":["Costes-Albrespic M"],"pubmed_abstract":["<h4>Rationale & objective</h4>Blood pressure (BP) control is essential for preventing cardiorenal complications in chronic kidney disease (CKD), but most patients fail to reach BP target. We assessed longitudinal patterns of antihypertensive drug prescription and systolic BP.<h4>Study design</h4>Prospective observational cohort study.<h4>Setting & population</h4>In total, 2,755 hypertensive patients with CKD stages 3-4, receiving care from a nephrologist, from the French CKD-Renal Epidemiology and Information Network (CKD-REIN cohort study).<h4>Exposure</h4>Patient factors, including sociodemographic characteristics, medical history, and laboratory data, and provider factors, including number of primary care physician and specialist encounters.<h4>Outcomes</h4>Changes in antihypertensive d"],"journal":["Kidney medicine"],"pagination":["100912"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11577237"],"repository":["biostudies-literature"],"pubmed_title":["Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study."],"pmcid":["PMC11577237"],"pubmed_authors":["Omorou A","Liabeuf S","Massy ZA","Laville S","Lange C","Fouque D","Lambert O","Metzger M","Costes-Albrespic M","Pecoits-Filho R","Alencar de Pinho N","Sautenet B","Pascal C","Hamroun A","Laville M","Jacquelinet C","CKD-REIN study group","Stengel B","Frimat L","Combe C"],"additional_accession":[]},"is_claimable":false,"name":"Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study.","description":"<h4>Rationale & objective</h4>Blood pressure (BP) control is essential for preventing cardiorenal complications in chronic kidney disease (CKD), but most patients fail to reach BP target. We assessed longitudinal patterns of antihypertensive drug prescription and systolic BP.<h4>Study design</h4>Prospective observational cohort study.<h4>Setting & population</h4>In total, 2,755 hypertensive patients with CKD stages 3-4, receiving care from a nephrologist, from the French CKD-Renal Epidemiology and Information Network (CKD-REIN cohort study).<h4>Exposure</h4>Patient factors, including sociodemographic characteristics, medical history, and laboratory data, and provider factors, including number of primary care physician and specialist encounters.<h4>Outcomes</h4>Changes in antihypertensive d","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Dec","modification":"2026-06-02T21:57:42.471Z","creation":"2025-04-04T02:57:42.435Z"},"accession":"S-EPMC11577237","cross_references":{"pubmed":["39574792"],"doi":["10.1016/j.xkme.2024.100912"]}}